Principle Wealth Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$480K Buy
12,663
+2,166
+21% +$100K 0.02% 266
2026
Q2
$503K Sell
10,497
-1,868
-15% -$80.3K 0.02% 257
2026
Q1
$454K Buy
12,365
+644
+5% +$30.5K 0.03% 252
2025
Q4
$596K Sell
11,721
-1,414
-11% -$72.3K 0.03% 220
2025
Q3
$729K Buy
13,135
+5,540
+73% +$324K 0.04% 190
2025
Q2
$524K Buy
7,595
+941
+14% +$64K 0.03% 228
2025
Q1
$462K Buy
6,654
+2,152
+48% +$178K 0.03% 235
2024
Q4
$387K Buy
4,502
+510
+13% +$55.2K 0.03% 253
2024
Q3
$475K Buy
3,992
+25
+0.6% +$3.33K 0.03% 231
2024
Q2
$566K Buy
3,967
+198
+5% +$26.2K 0.04% 204
2024
Q1
$484K Sell
3,769
-5
-0.1% -$595 0.04% 225
2023
Q4
$390K Buy
+3,774
New +$373K 0.03% 240
2020
Q3
– Sell
-2,000
Closed -$65K – 335
2020
Q2
$65K Buy
+2,000
New +$63.8K 0.02% 252

Other funds holding NVO

Principle Wealth Partners's NVO Position: Q3 2026 in Review

Principle Wealth Partners increased its Novo Nordisk (NVO) stake by 21% in Q3 2026, buying an estimated $100K and bringing the position to 12,663 shares worth $480K. The position accounts for 0.02% of the portfolio, ranked #266.

Principle Wealth Partners first reported a position in NVO in Q2 2020 and has held it in 13 quarters since. The position peaked at $729K in Q3 2025. 1,223 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Principle Wealth Partners held 12,663 shares of Novo Nordisk worth $480K as of Q3 2026.
  • Principle Wealth Partners bought 2,166 Novo Nordisk shares in Q3 2026, an estimated $100K.
  • Novo Nordisk made up 0.02% of Principle Wealth Partners's portfolio in Q3 2026, its #266 holding.
  • Principle Wealth Partners first reported a position in Novo Nordisk in Q2 2020 and has held it in 13 quarters since.
  • Principle Wealth Partners's Novo Nordisk position peaked at $729K in Q3 2025.
  • 1,223 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Principle Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.